PET diagnostic imaging with prostate-specific membrane antigen for prostate cancer a review of clinical utility, cost-effectiveness, diagnostic accuracy, and guidelines
This report aims to retrieve and review the cost-effectiveness, diagnostic accuracy, and evidence-based guidelines regarding PSMA PET imaging for patients with suspected or confirmed metastatic or BCR of prostate cancer
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa
Canadian Agency for Drugs and Technologies in Health
November 17, 2020, 2020
|
Edition: | Version:1.0 |
Series: | CADTH rapid response report: summary with critical appraisal
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | This report aims to retrieve and review the cost-effectiveness, diagnostic accuracy, and evidence-based guidelines regarding PSMA PET imaging for patients with suspected or confirmed metastatic or BCR of prostate cancer |
---|---|
Physical Description: | 1 PDF file (37 pages) illustration |